Initiation of dose expansion (Part 2) in select tumor cohorts with different EGFR levels is planned.Clinical trial information: NCT04626635.Neil Howard SegalMemorial Sloan Kettering Cancer Center, New York, NYEugenia GirdaDivision of Gynecologic Oncology, Rutgers Cancer Institute of New Jersey, New ...